These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19444112)
21. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. Caballería L; Pera G; Rodríguez L; Auladell MA; Bernad J; Canut S; Torán P Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1007-11. PubMed ID: 22668875 [TBL] [Abstract][Full Text] [Related]
22. Current and future therapeutic strategies in NAFLD. Mark N; de Alwis W; Day CP Curr Pharm Des; 2010 Jun; 16(17):1958-62. PubMed ID: 20370671 [TBL] [Abstract][Full Text] [Related]
23. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome. Cho KI; Jo EA; Cho SH; Kim BH Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857 [TBL] [Abstract][Full Text] [Related]
24. Advances in pediatric nonalcoholic fatty liver disease. Mencin AA; Lavine JE Pediatr Clin North Am; 2011 Dec; 58(6):1375-92, x. PubMed ID: 22093857 [TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease in children living in the obeseogenic society. Hesham A-Kader H World J Pediatr; 2009 Nov; 5(4):245-54. PubMed ID: 19911138 [TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. Chitturi S; Wong VW; Farrell G J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():163-72. PubMed ID: 21199528 [TBL] [Abstract][Full Text] [Related]
27. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229 [TBL] [Abstract][Full Text] [Related]
28. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. Zeb I; Katz R; Nasir K; Ding J; Rezaeian P; Budoff MJ J Cardiovasc Comput Tomogr; 2013; 7(5):311-8. PubMed ID: 24268118 [TBL] [Abstract][Full Text] [Related]
29. Pathogenesis and management issues for non-alcoholic fatty liver disease. Duvnjak M; Lerotić I; Barsić N; Tomasić V; Virović Jukić L; Velagić V World J Gastroenterol; 2007 Sep; 13(34):4539-50. PubMed ID: 17729403 [TBL] [Abstract][Full Text] [Related]
30. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. Bessone F; Dirchwolf M; Rodil MA; Razori MV; Roma MG Aliment Pharmacol Ther; 2018 Nov; 48(9):892-913. PubMed ID: 30194708 [TBL] [Abstract][Full Text] [Related]
32. Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. Al-Gayyar MM; Shams ME; Barakat EA Pharm Biol; 2012 Mar; 50(3):297-303. PubMed ID: 22103753 [TBL] [Abstract][Full Text] [Related]
33. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116 [TBL] [Abstract][Full Text] [Related]
34. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Pacifico L; Di Martino M; De Merulis A; Bezzi M; Osborn JF; Catalano C; Chiesa C Hepatology; 2014 Feb; 59(2):461-70. PubMed ID: 23843206 [TBL] [Abstract][Full Text] [Related]
35. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316 [TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640 [TBL] [Abstract][Full Text] [Related]
37. The obesity epidemic and nonalcoholic fatty liver disease in children. Dunn W; Schwimmer JB Curr Gastroenterol Rep; 2008 Feb; 10(1):67-72. PubMed ID: 18417045 [TBL] [Abstract][Full Text] [Related]
38. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196 [TBL] [Abstract][Full Text] [Related]
39. The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. Muhidin SO; Magan AA; Osman KA; Syed S; Ahmed MH J Obes; 2012; 2012():637538. PubMed ID: 23304464 [TBL] [Abstract][Full Text] [Related]
40. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study. Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]